These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36053993)

  • 1. The Emerging Drugs Network of Australia - Victoria Clinical Registry: A state-wide illicit substance surveillance and alert network.
    Syrjanen R; Schumann J; Fitzgerald J; Gerostamoulos D; Abouchedid R; Rotella JA; Knott J; Maplesden J; Hollerer H; Hannon L; Bourke E; Hodgson SE; Greene SL
    Emerg Med Australas; 2023 Feb; 35(1):82-88. PubMed ID: 36053993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A risk-based approach to community illicit drug toxicosurveillance: operationalisation of the Emerging Drugs Network of Australia - Victoria (EDNAV) project.
    Syrjanen R; Schumann JL; Lyons T; McKinnon G; Hodgson SE; Abouchedid R; Gerostamoulos D; Koutsogiannis Z; Fitzgerald J; Greene SL;
    Int J Drug Policy; 2023 Dec; 122():104251. PubMed ID: 37952318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and time course of benzodiazepine-type new psychoactive substance detections in Australia: results from the Emerging Drugs Network of Australia - Victoria project 2020-2022.
    Syrjanen R; Greene SL; Weber C; Smith JL; Hodgson SE; Abouchedid R; Gerostamoulos D; Maplesden J; Knott J; Hollerer H; Rotella JA; Graudins A; Schumann JL;
    Int J Drug Policy; 2023 Dec; 122():104245. PubMed ID: 37944339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From signal to alert: A cluster of exposures to counterfeit alprazolam tablets containing five novel benzodiazepines.
    Syrjanen R; Schumann J; Hodgson SE; Abouchedid R; Rotella JA; Graudins A; Greene SL
    Emerg Med Australas; 2023 Feb; 35(1):165-167. PubMed ID: 36271800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Emerging Drugs Network of Australia: A toxicosurveillance system of illicit and emerging drugs in the emergency department.
    Smith JL; Soderstrom J; Dawson A; Alfred S; Greene S; Isoardi K; McCutcheon D; Oosthuizen F; Ezard N; Burcham J; Fatovich DM;
    Emerg Med Australas; 2022 Feb; 34(1):58-64. PubMed ID: 34382338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytically confirmed illicit and novel psychoactive drug use in Western Australian emergency departments: initial results from the Emerging Drugs Network of Australia (EDNA).
    Weber C; Smith JL; Soderstrom J; Burrows S; McCutcheon D; Oosthuizen F; Fatovich DM;
    Clin Toxicol (Phila); 2023 Jul; 61(7):500-508. PubMed ID: 37449677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishing the protocols for the South Australian Emergency Department Admission Blood Psychoactive Testing (EDABPT) programme for drug surveillance.
    Partridge E; Alfred S; Camilleri A; Green H; Haustead D; Kostakis C; Mallon J; Mason K; Rivers-Kennedy A; Stockham P
    Emerg Med Australas; 2021 Oct; 33(5):883-887. PubMed ID: 33713558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-designing drug alerts for health and community workers for an emerging early warning system in Victoria, Australia.
    Brien R; Volpe I; Grigg J; Lyons T; Hughes C; McKinnon G; Tzanetis S; Crawford S; Eade A; Lee N; Barratt MJ
    Harm Reduct J; 2023 Mar; 20(1):30. PubMed ID: 36894933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An early warning system for emerging drugs of concern in the emergency department: Protocol for the Western Australian Illicit Substance Evaluation (WISE) study.
    McCutcheon D; Raghavan M; Soderstrom J; Oosthuizen F; Douglas B; MacDonald E; Fatovich D
    Emerg Med Australas; 2019 Jun; 31(3):411-416. PubMed ID: 30318770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The National Ambulance Surveillance System: A novel method for monitoring acute alcohol, illicit and pharmaceutical drug related-harms using coded Australian ambulance clinical records.
    Lubman DI; Matthews S; Heilbronn C; Killian JJ; Ogeil RP; Lloyd B; Witt K; Crossin R; Smith K; Bosley E; Carney R; Wilson A; Eastham M; Keene T; Shipp C; Scott D
    PLoS One; 2020; 15(1):e0228316. PubMed ID: 32004349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening major trauma patients for prevalence of illicit drugs.
    Knott J; Yap C; Mitra B; Gerdtz M; Daniel C; Braitberg G
    Drug Alcohol Rev; 2022 Jan; 41(1):285-292. PubMed ID: 34263497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug trends and harm related to new psychoactive substances (NPS) in Sweden from 2010 to 2016: Experiences from the STRIDA project.
    Helander A; Bäckberg M; Beck O
    PLoS One; 2020; 15(4):e0232038. PubMed ID: 32324788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A feasible model for early intervention for high-risk substance use in the emergency department setting.
    Howard R; Fry S; Chan A; Ryan B; Bonomo Y
    Aust Health Rev; 2019 Apr; 43(2):188-193. PubMed ID: 29298737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergency department visits due to new psychoactive substances and other illicit drugs in Taiwan: preliminary results of the Taiwan Emergency Department Drug Abuse Surveillance (TEDAS) project.
    Lin CC; Weng TI; Ng CJ; Shih CP; Hsu J; Liao YC; Yang CC; Fang CC;
    Clin Toxicol (Phila); 2022 Jun; 60(6):708-715. PubMed ID: 35315299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-fatal intoxications involving the novel benzodiazepine clonazolam: case series from the Emerging Drugs Network of Australia - Victoria project.
    Syrjanen R; Greene SL; Castle JW; Di Rago M; Hodgson SE; Abouchedid R; Graudins A; Schumann JL
    Clin Toxicol (Phila); 2023 Apr; 61(4):290-293. PubMed ID: 36988452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggression and violence at ambulance attendances where alcohol, illicit and/or pharmaceutical drugs were recorded: A 5-year study of ambulance records in Victoria, Australia.
    Coomber K; Curtis A; Vandenberg B; Miller PG; Heilbronn C; Matthews S; Smith K; Wilson J; Moayeri F; Mayshak R; Lubman DI; Scott D
    Drug Alcohol Depend; 2019 Dec; 205():107685. PubMed ID: 31704380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Snapshot of narcotic drugs and psychoactive substances in Kuwait: analysis of illicit drugs use in Kuwait from 2015 to 2018.
    Al-Matrouk A; Al-Hasan M; Naqi H; Al-Abkal N; Mohammed H; Haider M; Al-Shammeri D; Bojbarah H
    BMC Public Health; 2021 Apr; 21(1):671. PubMed ID: 33827491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current European data collection on emergency department presentations with acute recreational drug toxicity: gaps and national variations.
    Heyerdahl F; Hovda KE; Giraudon I; Yates C; Dines AM; Sedefov R; Wood DM; Dargan PI
    Clin Toxicol (Phila); 2014 Dec; 52(10):1005-12. PubMed ID: 25361166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Psychoactive Substances and receding COVID-19 pandemic: really going back to "normal"?
    Napoletano S; Basile G; Lo Faro AF; Negro F
    Acta Biomed; 2022 May; 93(2):e2022186. PubMed ID: 35545997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing wastewater to detect illicit drugs: state of the art, potential and research needs.
    Castiglioni S; Thomas KV; Kasprzyk-Hordern B; Vandam L; Griffiths P
    Sci Total Environ; 2014 Jul; 487():613-20. PubMed ID: 24963530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.